GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: AIC499 is a monocyclic β-lactam (monobactam) antibacterial that inhibits the penicillin-binding proteins of Gram-negative bacteria and demonstrates excellent activity against Gram-negative pathogens, including multi-drug resistant (MDR) clinical isolates [1].
|
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Freischem S, Grimm I, López-Pérez A, Willbold D, Klenke B, Vuong C, Dingley AJ, Weiergräber OH. (2021)
Interaction Mode of the Novel Monobactam AIC499 Targeting Penicillin Binding Protein 3 of Gram-Negative Bacteria. Biomolecules, 11 (7). [PMID:34356681] |
|
2. Prasad NK, Seiple IB, Cirz RT, Rosenberg OS. (2022)
Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020. Antimicrob Agents Chemother, 66 (5): e0005422. [PMID:35471042] |